Cancer Research
Blood Test Reveals Hidden Cancer Resistance in Prostate Cancer Patients
New study shows circulating tumor cells can predict treatment response and reveal drug resistance patterns.
Research Paper
Mar 29, 2026 0
Results for "Plasma p-tau217" in Cancer
20 articles
Cancer Research
Pfizer Terminates Phase 1 Trial of Novel Anti-PD-1/IL-15 Fusion Protein in Solid Tumors
Pfizer's first-in-human trial of PF-07209960, a dual-action immunotherapy fusion protein, was terminated after enrolling 37 patients.
Clinical Trial
May 14, 2026 0
Cancer Research
PSMA Imaging Predicts Prostate Cancer Treatment Response in New Trial
Early PSMA upregulation after enzalutamide predicts shorter survival, but adding Lu-177-PSMA-617 improves outcomes in resistant prostate cancer.
Research Paper
Apr 16, 2026 0
Cancer Research
Urine Test May Soon Track Senescent Cells in Cancer and Fibrosis
Cambridge scientists engineer a nanoprobe that detects therapy-induced senescence non-invasively through a simple urine colorimetric test.
Research Paper
May 14, 2026 0
Cancer Research
Combined PET and Blood Tests Predict Lymphoma Relapse Risk with 85% Accuracy
New study shows combining PET scans with blood DNA tests can identify follicular lymphoma patients at high risk of early relapse.
Research Paper
Apr 2, 2026 0
Cancer Research
Pfizer Tests Novel CD47-PD-L1 Bispecific Antibody in Advanced Solid Tumors
A first-in-human Phase 1 trial evaluates PF-07257876, a dual-checkpoint bispecific antibody targeting both CD47 and PD-L1, in hard-to-treat cancers.
Clinical Trial
May 21, 2026 0
Cancer Research
New ADC Drug Shows Promise in Lung Cancer With Key Biomarker Clues
A phase 2 trial of datopotamab deruxtecan in 100 NSCLC patients reveals a 26% response rate and critical resistance biomarkers.
Research Paper
Apr 20, 2026 0
Cancer Research
Combined ctDNA and PSA Testing Predicts Survival in Metastatic Prostate Cancer
A prospective cohort study shows combining ctDNA with PSA levels dramatically improves survival prediction in high-volume metastatic prostate cancer patients.
Research Paper
May 17, 2026 0
Cancer Research
New Cancer Drug NT-I7 Boosts Immune Cells in Brain Tumor Patients for 12+ Weeks
Phase I trial shows NT-I7 safely increases lymphocyte counts and expands cancer-fighting T cells in high-grade glioma patients.
Research Paper
Mar 28, 2026 0
Cancer Research
Urine Test Predicts Cancer Immunotherapy Success in Biliary Tract Tumors
New non-invasive urine protein test accurately predicts which biliary tract cancer patients will respond to immunotherapy treatment.
Research Paper
Apr 3, 2026 0
Cancer Research
Talquetamab Shows 60% Response Rate in Japanese Myeloma Patients with No Dose-Limiting Toxicity
Phase 1 data from 15 heavily pretreated Japanese myeloma patients confirms talquetamab's safety and efficacy, matching global trial results.
Research Paper
Jun 15, 2026 0
Cancer Research
Blood Test Detects Early Breast Cancer with 95% Accuracy Using DNA Fragments
New liquid biopsy analyzes DNA fragments in blood to detect breast cancer early, determine subtypes, and assess lymph node spread.
Research Paper
Mar 28, 2026 1
Cancer Research
Blood Test Using Extracellular Vesicles Detects Early Colorectal Cancer
New ColonTrack model identifies early-stage colorectal cancer with 94% accuracy using three proteins from blood-based extracellular vesicles.
Research Paper
Apr 2, 2026 0
Cancer Research
Pertuzumab Retreatment Extends Survival in HER2-Positive Breast Cancer by 10 Months
Japanese trial shows dual HER2 blockade with pertuzumab plus trastuzumab improves overall survival even after prior pertuzumab treatment.
Research Paper
Apr 2, 2026 0
Cancer Research
Liquid Biopsy Guides Targeted Lung Cancer Treatment in Breakthrough Trial
New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Nanoparticle Blood Tests Detect Multiple Cancers with 90% Accuracy in Early Stages
Revolutionary liquid biopsy technology uses nanoparticles to detect cancer biomarkers in blood with exceptional precision.
Research Paper
Mar 29, 2026 0
Cancer Research
Targeted Therapy Shows Promise for Aggressive Brain Cancer in Precision Medicine Trial
Phase 1/2 umbrella trial matches glioblastoma patients to targeted treatments based on tumor genetics, with temsirolimus showing significant benefit.
Research Paper
Apr 4, 2026 0
Cancer Research
Dual Drug Combo Radiosensitizes ATM-Mutant Prostate Cancer
New study reveals combination therapy targeting ATR and DNA-PKcs kinases dramatically improves radiation response in ATM-deficient prostate cancers.
Research Paper
Apr 17, 2026 0
Cancer Research
New Blood Test Panels Outperform Standard Screening for Pancreatic Cancer Detection
Advanced biomarker combinations show 96% accuracy in detecting pancreatic cancer, significantly better than current standard tests.
Research Paper
Mar 28, 2026 0
Cancer Research
PD-L1 and TERT Mutations Flag Aggressive Thyroid Cancers for Immunotherapy
A 73-patient study finds PD-L1 expression and TERT mutations identify high-grade thyroid cancers most likely to benefit from checkpoint inhibitor therapy.
Research Paper
Apr 28, 2026 0
Page 1 of 2Next